MetaCap

Avalyn Pharma (AVLN) vs Innoviva (INVA)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Innoviva is the larger company by market cap ($1.31 billion vs $1.26 billion), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

AVLN-3.70%INVA-19.92%
+36%+6%-24%
Apr 30, 20261 yearNov 20, 2026
AVLN-4.83%INVA-20.34%
+34%+5%-23%
Apr 27, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

AVLN versus INVA key metrics
MetricAVLNINVA
Share price$28.40$18.41
Market cap$1.26B$1.31B
1-day change-1.05%0.00%
YTD return—-7.90%
1-year return—-12.17%
5-year return—+8.81%
P/E ratio (TTM)—7.83
Forward P/E—8.33
EPS (TTM)$-3.96$2.35
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$411.33M
Revenue growth (YoY)—+14.67%
Net income (latest FY)—$271.17M
Gross margin—74.80%
Operating margin—39.81%
Net margin—65.92%
52-week high$40.17$25.15
52-week low$22.24$18.19
Distance from 52-week high-29.30%-26.80%
Analyst consensusstrong_buybuy
Avg. price target upside+114.79%+89.03%
Average volume352.95K865.66K
Shares outstanding44.52M71.08M
Employees56159
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Avalyn Pharma

AVLN stock →

Avalyn Pharma Inc. operates as a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases.

Health Care · Biotechnology: Pharmaceutical Preparations · 56 employees

About Innoviva

INVA stock →

Innoviva, Inc. operates as a biopharmaceutical company in the United States and internationally.

Health Care · Biotechnology: Pharmaceutical Preparations · 159 employees

AVLN vs INVA FAQ

Which is bigger, Avalyn Pharma or Innoviva?

Innoviva (INVA) is larger, with a market capitalization of $1.31B compared with $1.26B for Avalyn Pharma (AVLN).

Are Avalyn Pharma and Innoviva in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons